PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16786000-6 2006 We found that the 14-3-3sigma expression is lost in LNCaP and Tramp-C1 prostate cancer cell lines and that this expression is restored after treatment with epigenetic silencing modifiers 5-aza-2"-deoxycytidine (5-aza) and trichostatin A (TSA). Decitabine 187-209 stratifin Homo sapiens 18-29 16786000-6 2006 We found that the 14-3-3sigma expression is lost in LNCaP and Tramp-C1 prostate cancer cell lines and that this expression is restored after treatment with epigenetic silencing modifiers 5-aza-2"-deoxycytidine (5-aza) and trichostatin A (TSA). Azacitidine 187-192 stratifin Homo sapiens 18-29 16786000-6 2006 We found that the 14-3-3sigma expression is lost in LNCaP and Tramp-C1 prostate cancer cell lines and that this expression is restored after treatment with epigenetic silencing modifiers 5-aza-2"-deoxycytidine (5-aza) and trichostatin A (TSA). trichostatin A 222-236 stratifin Homo sapiens 18-29 16786000-6 2006 We found that the 14-3-3sigma expression is lost in LNCaP and Tramp-C1 prostate cancer cell lines and that this expression is restored after treatment with epigenetic silencing modifiers 5-aza-2"-deoxycytidine (5-aza) and trichostatin A (TSA). trichostatin A 238-241 stratifin Homo sapiens 18-29 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. Azacitidine 79-84 stratifin Homo sapiens 31-42 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. Azacitidine 79-84 methyl-CpG binding protein 2 Homo sapiens 126-130 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. Azacitidine 79-84 stratifin Homo sapiens 140-151 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. Azacitidine 79-84 translocating chain-associating membrane protein 1 Mus musculus 196-201 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. trichostatin A 89-92 stratifin Homo sapiens 31-42 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. trichostatin A 89-92 methyl-CpG binding protein 2 Homo sapiens 126-130 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. trichostatin A 89-92 stratifin Homo sapiens 140-151 16786000-10 2006 In addition, the activation of 14-3-3sigma gene expression by a combination of 5-aza and TSA also involves the release of the MBD2 from the 14-3-3sigma promoter-methylated CpG island in LNCaP and Tramp-C1 cells. trichostatin A 89-92 translocating chain-associating membrane protein 1 Mus musculus 196-201 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. Azacitidine 240-245 stratifin Homo sapiens 32-43 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. Azacitidine 240-245 translocating chain-associating membrane protein 1 Mus musculus 66-71 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. Azacitidine 240-245 proliferating cell nuclear antigen Mus musculus 185-189 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. Azacitidine 240-245 stratifin Homo sapiens 212-223 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. trichostatin A 250-253 stratifin Homo sapiens 32-43 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. trichostatin A 250-253 translocating chain-associating membrane protein 1 Mus musculus 66-71 16786000-13 2006 Interestingly, we observed that 14-3-3sigma-inactivated LNCaP and Tramp-C1 cells had markedly decreased cell proliferation and protein expression of proliferation cell nuclear antigen (PCNA) after restoration of 14-3-3sigma expression with 5-aza and TSA treatment. trichostatin A 250-253 proliferating cell nuclear antigen Mus musculus 185-189